Lastly, a systemic vasculitis develops, which is characterized by granulomatous inflammation, typically within three years of onset. Drug-induced small vessel vasculitis develops within 1 to 3 ...

The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), released three new guidelines for the treatment and management of systemic vasculitis. Vasculitis is ...

Three new guidelines have been released for the treatment and management of systemic vasculitis ... Recommendations for TAK include the use of non-glucocorticoid immunosuppressive agents with ...

The treatment of systemic necrotizing vasculitis has made great strides in both efficacy and outcomes. Standard therapies, however, are associated with numerous side effects, and not all patients ...

Their findings, recently published in The Lancet Rheumatology, offer new insights into the diagnosis and treatment of systemic vasculitis, a group of rare and complex autoimmune diseases.

Necrotizing vasculitis, or systemic necrotizing vasculitis (SNV), is an inflammation of blood vessel walls. It typically affects small and medium blood vessels. This inflammation can interrupt ...

ATLANTA — A first look at new guidelines for the treatment of gout was presented here at the American College of Rheumatology (ACR) 2019 Annual Meeting. A key update is to use a treat-to-target ...

secondary cerebral vasculitis (which can occur in connective-tissue diseases), systemic vasculitis, and infections. Early recognition is important because treatment with glucocorticoids with or ...

Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis is a severe condition ... Removal of SNPs mapping to the MHC locus showed that non–MHC-linked loci also contribute to ...